Research & Education

IASLC Names Fred R. Hirsch, MD, PhD as New CEO

Dr. Hirsch will replace Dr. Paul A. Bunn, Jr. after World Conference in 2013
October 9, 2013

The International Association for the Study of Lung Cancer (IASLC) Board of Directors has selected Fred R. Hirsch, MD, PhD as the organization’s new Chief Executive Officer (CEO). Dr. Hirsch will take over for the current CEO, Dr. Paul A. Bunn, Jr. MD following the World Conference on Lung Cancer in Sydney, October 27-30, 2013 where Dr. Bunn’s term ends.

“Dr. Hirsch is an outstanding choice for the Chief Executive Officer of the IASLC and I am proud to announce that he will replace me in this role,” says Dr. Bunn. “I was pleased to succeed Dr. Heine H. Hansen as CEO in 2003 and have been proud to serve the IASLC over the past 10 years as it matured into an important resource in thoracic cancers. Since Dr. Hirsch worked with both Drs. Hansen and myself and since he has served the IASLC well in many capacities, the IASLC will be well served by his selection as CEO.”

Dr. Hirsch is a Professor of Medicine and Pathology at the University of Colorado School of Medicine in Aurora, Colorado, USA. His research interests include translational research, biomarkers and targeted therapies, and early detection of lung cancer. Dr. Hirsch’s research has helped identify and validate prognostic markers for lung cancer outcomes and predictive markers for personalized lung cancer therapies. Dr. Hirsch is the principle investigator on an NCI SPECS grant to establish biomarkers for squamous cell lung cancer and chairs the translational research component of the SWOG lung cancer committee. He holds a medical degree and doctorate from the University of Copenhagen and a degree from the Copenhagen Business School. His specialty is medical oncology, but trained in pathology as well.

Dr. Hirsch has been an active member of the IASLC since 1977. He has served as Chair of the Pathology Committee, Chair of the Prevention and Early Detection Committee and is Associate Editor for the IASLC Journal: Journal of Thoracic Oncology. He has served on the Board of Directors for IASLC since 2005, and he currently serves as the Treasurer of IASLC. He was the editor of the IASLC newsletter from 2000-2013 when his term ended.  He received the Mary J. Matthews Award in 2007 for life-time achievements in pathology and translational research of thoracic malignancies. He is the Congress President for the 16th World Conference on Lung Cancer to be held in Denver, CO, USA in 2015.